Kevin Koch Edgewise Therapeutics, Inc. (EWTX) insider trading activity

EWTX Quotes by TradingView

Kevin Koch is President and CEO of Edgewise Therapeutics, Inc.. Currently has a direct ownership of 14,478 shares of EWTX, which is worth approximately $462,572. The most recent transaction as insider was on May 02, 2024, when has been sold 3,152 shares (Common Stock) at a price of $18.91 per share, resulting in proceeds of $59,604. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.5K
0% 3M change
100.72% 12M change
Total Value Held $462,572

KEVIN KOCH Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 02 2024
SELL
Open market or private sale
$59,604 $18.91 p/Share
3,152 Reduced 17.88%
14,478 Common Stock
May 01 2024
BUY
Exercise of conversion of derivative security
-
10,417 Added 37.14%
17,630 Common Stock
May 02 2023
SELL
Open market or private sale
$28,506 $8.9 p/Share
3,203 Reduced 30.75%
7,213 Common Stock
May 01 2023
BUY
Exercise of conversion of derivative security
-
10,416 Added 50.0%
10,416 Common Stock
KK

Kevin Koch

President and CEO
Boulder, CO

Track Institutional and Insider Activities on EWTX

Follow Edgewise Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EWTX shares.

Notify only if

Insider Trading

Get notified when an Edgewise Therapeutics, Inc. insider buys or sells EWTX shares.

Notify only if

News

Receive news related to Edgewise Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EWTX